Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
53
self-reported 51–200 band
Founded
2006
20 years
Registry matches
1
ABR
Office countries
1
1 address
Funding rounds
2
Post IPO equity · Nov 2024 · US$ 11.2M
Company type
Public Company
self-reported
Legal entity
1 brand → 1 possible registrationMatched by name against ABR, so this is a candidate list, not a confirmed identity. Confidence and match method are shown against every row.
ORTHOCELL LIMITED
ABN57118897135
Legal entities
Show as table · Orthocell Ltd: 1 registry entity
| ORTHOCELL LIMITED | ABN 57118897135 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Description
Orthocell is a regenerative medicine company dedicated to the development of breakthrough products to unlock the power of the human body to heal - restoring mobility, function and performance. Its is listed on the Australian Stock Exchange (ASX:OCC).
Orthocell's research has led to the development of a number of regenerative medical products and devices from autologous cell therapies to collagen medical devices manufactured by Orthocell Ltd, in Perth Western Australia, using the proprietary SMRT™ manufacturing process.
Remplir™ is a sterile, resorbable collagen nerve wrap used by surgeons to assist in the repair and protection of peripheral nerve injuries. Remplir™ is approved for sale in multiple major markets around the World.
Striate+™ is a sterile, resorbable collagen membrane, primarily used in dental surgery to support guided bone regeneration (GBR) and guided tissue regeneration (GTR). It is distributed globally through a partnership with BioHorizons.
SmrtGraft™ is a sterile, bio-resorbable collagen scaffold used to augment the surgical repair of damaged or torn human tendon tissue.
OrthoACI™ (Autologous Chondrocyte Implantation) is a personalised cell therapy used to repair and regenerate damaged articular cartilage in joints, primarily in the knee and ankle. It uses a patient's own healthy tendon cells to stimulate regeneration and repair damaged tissue.
OrthoATI™ (Autologous Tenocyte Implantation) is a personalised cell therapy used to treat chronic, degenerative tendon injuries. It uses a patient's own healthy tendon cells to stimulate regeneration and repair damaged tissue.
Specialties
All 8 specialties
- Medical Devices
- Regenerative medicine
- Biotechnology
- Soft tissue repair
- Stem cell therapy
- orthopaedics
- sports science
- exercise physiology
Related specialties
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
Addresses
- AUBuilding 191; Murdoch University; Perth, Western Australia 6150Primary
Grid intelligence Members
Funding
Last round · 25 November 2024US$ 11.2MPost IPO equity
Rounds2
Round typePost IPO equity · secondary transaction
Amount (USD)11,200,000
Stage rank6
Investors named1
Since last round1 yr 1 mo
Funding
Show as table · 2 funding rounds
| Rounds | 2 |
|---|---|
| Axis | 2006 to 2026 |
| Post IPO equity · 25 Nov 2024 | US$ 11.2M |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
FAQ
Which legal entity operates under Orthocell Ltd?
One Western Australia entity on the ABR: ORTHOCELL LIMITED (ABN 57 118 897 135), medium confidence.
How many people work at Orthocell Ltd?
53 counted staff profiles at January 2026, inside the self-reported 51–200 band.
Where does Orthocell Ltd have offices?
One address on record, Australia only. Primary: Building 191, Murdoch University, Perth, Western Australia 6150.
Has Orthocell Ltd raised funding?
Two rounds. Latest 25 November 2024: post IPO equity, US$11,200,000.
What does Orthocell Ltd list as its specialties?
Eight tags on the brand's own list, among them orthopaedics, biotechnology and sports science.
Which companies are listed alongside Orthocell Ltd?
41 profiles list Orthocell Ltd as a peer — 98th percentile in Biotechnology Research. It lists ten peers of its own. Cynata Therapeutics and Argenica Therapeutics list it back.